INTEC PHARMA LTD JERUSALEM's ticker is and the CUSIP is M53644106. A total of 25 filers reported holding INTEC PHARMA LTD JERUSALEM in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $73,000 | – | 14,098 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 1,125,153 | $4,951,000 | 3.63% |
| ACUTA CAPITAL PARTNERS, LLC | 2,962,568 | $13,035,000 | 2.32% |
| DAFNA Capital Management LLC | 568,600 | $2,502,000 | 1.17% |
| MEITAV INVESTMENT HOUSE LTD | 2,450,592 | $11,425,000 | 0.51% |
| SECTORAL ASSET MANAGEMENT INC | 890,386 | $3,918,000 | 0.44% |
| Avoro Capital Advisors LLC | 2,570,705 | $11,311,000 | 0.44% |
| Cormorant Asset Management, LP | 773,816 | $3,405,000 | 0.25% |
| CAXTON CORP | 64,817 | $285,000 | 0.10% |
| Migdal Insurance & Financial Holdings Ltd. | 522,067 | $2,297,000 | 0.06% |
| 683 Capital Management, LLC | 150,000 | $660,000 | 0.04% |